Shares of Unichem Laboratories declined more than 3% in early trade on May 25 after the company reported a sharp fall in consolidated profit for the quarter ended March 2026.
The company reported a consolidated net profit of Rs 10.9 crore in Q4FY26, marking a decline of 79.4% compared to Rs 53 crore in the corresponding quarter last year.
Revenue from operations also slipped 2.1% year-on-year to Rs 575 crore versus Rs 587 crore reported in the same period previous year.
Operating performance remained under pressure during the quarter. EBITDA fell 43% YoY to Rs 47.7 crore from Rs 83.7 crore, while EBITDA margin narrowed to 8.3% from 14.3% in the year-ago period.
The sharp decline in profitability and margins weighed on investor sentiment, leading to selling pressure in the stock during morning trade.
Unichem Laboratories Share Price Performance
As of 9:34 AM:
- Today’s High: Rs 364.95
- Today’s Low: Rs 350.05
- Opening Price: Rs 361.05
- Previous Close: Rs 370.85
- 52-Week High: Rs 668.00
- 52-Week Low: Rs 278.20
The stock remains significantly below its 52-week high level amid continued volatility in the pharmaceutical sector.
Disclaimer: The information provided in this article is for informational purposes only and should not be considered as investment advice, stock recommendation, or financial guidance. Stock market investments are subject to market risks, and past performance does not guarantee future returns. Investors are advised to conduct their own research, evaluate financial conditions carefully, and consult a qualified financial advisor before making any investment decisions. The publication and author are not responsible for any losses incurred based on this information.